Safety Emporium eyewashes
Safety Emporium eyewashes

Interactive Learning Paradigms, Incorporated

DCHAS-L Discussion List Archive

About This Archive  |   DCHAS-L 2021 Index   |   DCHAS-L Yearly Index   |   DCHAS-L Home Page

About This Archive

DCHAS-L 2021 Index

DCHAS-L Yearly Index

DCHAS-L Yearly Index

DCHAS-L Home Page


From: Eugene Ngai <eugene_ngai**At_Symbol_Here**COMCAST.NET>
Subject: [DCHAS-L] Metal Hydride Gas Medical Treatment for Exposure
Date: Fri, 28 May 2021 14:04:53 -0400
Reply-To: ACS Division of Chemical Health and Safety <DCHAS-L**At_Symbol_Here**Princeton.EDU>
Message-ID: 034f01d753eb$f6b2ec60$e418c520$**At_Symbol_Here**comcast.net

Demystify: 

I coauthored an article on metal hydride gas acute exposures and medical treatment with Steven Curry M.D. (University of Arizona College of Medicine – Phoenix) and George Warpinski, M.D.(Banner – University Medical Center Phoenix) titled “Tox and Hound – Fellow Friday – Metal Hydrides I” This has been a very productive relationship since they are very familiar with toxic affects and medical treatment of these gases while my background is on the manufacturing and use. We all have a total of more than 100 years of experience! We shared a lot of incident information as well as lessons learned. From our archives we shared articles and reports that many have forgotten or are not aware of since some are 40 years old. Some triggered significant change to the way the gas industry packages and/or transports these gases.

I wished we would have collaborated earlier and done some training together.

In this first chapter our focus is primarily on arsine, germane and hydrogen selenide. Future chapters will be on phosphine, diborane and pentaborane.

Please visit the blog to see the article

https://emcrit.org/emcrit/tox-and-hound-fellow-friday-metal-hydrides-i/

 

 

Eugene Ngai

Chemically Speaking LLC

www.chemicallyspeakingllc.com

 

Previous post   |  Top of Page   |   Next post